Expression pattern of REIC/Dkk-3 in various cell types and the implications of the soluble form in prostatic acinar

Kai Zhang1, Masami Watanabe, Yuji Kashiwakura

  • 1Innovation Center Okayama for Nanobio-Targeted Therapy, Okayama University, Okayama, Japan.

Insights

The tumor suppressor REIC/Dkk-3, a secretory protein, is downregulated in cancers. It plays a role in normal tissue architecture, particularly prostatic acinar development, via autocrine or paracrine signaling.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • REIC/Dkk-3 is a tumor suppressor and secretory protein.
  • It was initially identified as downregulated in human immortalized cells.

Purpose of the Study:

  • To investigate the expression pattern of REIC/Dkk-3 in various cell types.
  • To characterize the physiological functions of REIC/Dkk-3.
  • To explore its role in prostatic acinar development.

Main Methods:

  • Examined REIC/Dkk-3 expression in cancer cell lines and normal mouse organs.
  • Utilized immunohistochemical analyses and confocal microscopy.
  • Assessed the effects of recombinant REIC/Dkk-3 on RWPE-1 cell morphogenesis.

Main Results:

  • REIC/Dkk-3 was significantly downregulated in all tested cancer cell types.
  • Ubiquitous expression was observed in normal mouse organs, abundant in liver, heart, and brain.
  • REIC/Dkk-3 promoted prostatic acinar morphogenesis in vitro.

Conclusions:

  • REIC/Dkk-3 expression is altered in cancer.
  • The protein is widely distributed in normal tissues.
  • REIC/Dkk-3 influences normal tissue architecture, potentially via autocrine/paracrine signaling.